ATE397005T1 - Sialyl-lewisa und sialyl-lewisx epitope analoge - Google Patents
Sialyl-lewisa und sialyl-lewisx epitope analogeInfo
- Publication number
- ATE397005T1 ATE397005T1 AT97901068T AT97901068T ATE397005T1 AT E397005 T1 ATE397005 T1 AT E397005T1 AT 97901068 T AT97901068 T AT 97901068T AT 97901068 T AT97901068 T AT 97901068T AT E397005 T1 ATE397005 T1 AT E397005T1
- Authority
- AT
- Austria
- Prior art keywords
- sialyl
- lewisa
- lewisx
- epitope analogue
- epitope
- Prior art date
Links
- LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 title abstract 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 1
- 125000003047 N-acetyl group Chemical group 0.000 abstract 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH22996 | 1996-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE397005T1 true ATE397005T1 (de) | 2008-06-15 |
Family
ID=4182238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97901068T ATE397005T1 (de) | 1996-01-30 | 1997-01-17 | Sialyl-lewisa und sialyl-lewisx epitope analoge |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6187754B1 (de) |
| EP (1) | EP0886639B1 (de) |
| AT (1) | ATE397005T1 (de) |
| AU (1) | AU1444697A (de) |
| DE (1) | DE69738731D1 (de) |
| WO (1) | WO1997028174A1 (de) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060189547A1 (en) | 2000-04-12 | 2006-08-24 | Christian Samuel T | Novel pharmaceutical agents containing carbohydrate moieties and methods of their preparation and use |
| US6548484B1 (en) * | 2000-04-12 | 2003-04-15 | International Medical Innovations, Inc. | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
| US9302982B2 (en) | 2000-04-12 | 2016-04-05 | Glycon Llc | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use |
| US7345031B2 (en) | 2000-04-12 | 2008-03-18 | International Medical Innovations, Inc. | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use |
| FR2827599A1 (fr) * | 2001-07-20 | 2003-01-24 | Neuro3D | Composes derives de quinoleine et quinoxaline,preparation et utilisations |
| FI20011664L (fi) * | 2001-08-17 | 2003-02-18 | Carbion Oy | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö |
| WO2003097658A2 (en) * | 2002-05-16 | 2003-11-27 | Glycomimetics, Inc. | Compounds and methods for inhibiting selectin-mediated function |
| JP2006502986A (ja) * | 2002-07-03 | 2006-01-26 | グリコミメティクス， インコーポレイテッド | 新脈管形成に関与する医学的状態の診断および治療のための組成物および方法 |
| AU2003301209A1 (en) * | 2002-12-20 | 2004-07-22 | Glycomimetics, Inc. | Oligosaccharides and conjugates thereof for the treatement of pseudomonas bacteria infection |
| US20040219158A1 (en) * | 2003-05-02 | 2004-11-04 | Glycomimetics, Inc. | Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria |
| EP1763533B1 (de) * | 2003-11-19 | 2008-01-09 | GlycoMimetics, Inc. | Spezifischer antagonist sowohl für e- als auch p-selektine |
| WO2005054264A2 (en) * | 2003-11-19 | 2005-06-16 | Glycomimetics, Inc. | Glycomimetic antagonists for both e- and p-selectins |
| US8201377B2 (en) * | 2004-11-05 | 2012-06-19 | Faus Group, Inc. | Flooring system having multiple alignment points |
| US20090036386A1 (en) * | 2005-05-25 | 2009-02-05 | Glycomimetics, Inc | Heterobifunctional compounds for selectin inhibition |
| CN101291946B (zh) * | 2005-08-09 | 2011-06-29 | 糖模拟物有限公司 | 对来自假单胞菌的pa-il凝集素、pa-iil凝集素或其两者的糖模拟物抑制剂 |
| PL2264043T3 (pl) | 2005-09-02 | 2018-04-30 | Glycomimetics, Inc. | Heterobifunkcyjne inhibitory pan-selektyny |
| US20090176717A1 (en) * | 2006-06-01 | 2009-07-09 | Glycomimetics, Inc. | Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas |
| EP2074132B1 (de) | 2006-10-12 | 2013-05-15 | GlycoMimetics, Inc. | Glycomimetischer ersatz für hexosen und n-acetyl-hexosamine |
| AU2008216794A1 (en) * | 2007-02-09 | 2008-08-21 | Glycomimetics, Inc. | Methods of use of glycomimetics with replacements for hexoses and N-acetyl hexosamines |
| US8039442B2 (en) | 2007-07-18 | 2011-10-18 | Glycomimetics, Inc. | Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| WO2009126556A1 (en) | 2008-04-08 | 2009-10-15 | Glycomimetics, Inc. | Pan-selectin inhibitor with enhanced pharmacokinetic activity |
| CN102088983B (zh) * | 2008-06-13 | 2013-01-30 | 糖模拟物有限公司 | 利用选择的糖模拟化合物的血液癌症的治疗 |
| CA2760292A1 (en) * | 2009-05-01 | 2010-11-04 | Glycomimetics, Inc. | Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors |
| US8343971B2 (en) * | 2009-09-15 | 2013-01-01 | Rutgers, The State University Of New Jersey | Pharmacologically-active vanilloid carbamates |
| US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
| KR102055958B1 (ko) | 2011-12-22 | 2019-12-13 | 글리코미메틱스, 인크. | E-셀렉틴 길항제 화합물, 조성물, 및 이용 방법 |
| GB201214736D0 (en) * | 2012-08-17 | 2012-10-03 | Isis Innovation | Inflammation imaging and therapy |
| US9867841B2 (en) | 2012-12-07 | 2018-01-16 | Glycomimetics, Inc. | Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells |
| JP6689854B2 (ja) | 2014-12-03 | 2020-04-28 | グリコミメティクス， インコーポレイテッド | Ｅ−セレクチンおよびｃｘｃｒ４ケモカイン受容体のヘテロ二官能性阻害剤 |
| JP2019502727A (ja) | 2016-01-22 | 2019-01-31 | グリコミメティクス， インコーポレイテッド | Ｐａ−ｉｌおよび／またはｐａ−ｉｉｌレクチンの糖模倣体阻害剤 |
| WO2017151708A1 (en) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin |
| US11433086B2 (en) | 2016-08-08 | 2022-09-06 | Glycomimetics, Inc. | Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 |
| AU2017341065B2 (en) | 2016-10-07 | 2023-04-06 | Crescent Biopharma, Inc. | Highly potent multimeric E-selectin antagonists |
| EP3596096A1 (de) | 2017-03-15 | 2020-01-22 | GlycoMimetics, Inc. | Galactopyranosyl-cyclohexyl-derivate als e-selectin-antagonisten |
| JP7275131B2 (ja) | 2017-11-30 | 2023-05-17 | グリコミメティクス， インコーポレイテッド | 骨髄浸潤リンパ球を動員する方法、およびその使用 |
| KR20200104889A (ko) | 2017-12-29 | 2020-09-04 | 글리코미메틱스, 인크. | E-셀렉틴 및 갈렉틴-3의 이종이기능성 억제제 |
| KR20200128025A (ko) | 2018-03-05 | 2020-11-11 | 글리코미메틱스, 인크. | 급성 골수성 백혈병 및 관련 병태의 치료 방법 |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925796A (en) * | 1986-03-07 | 1990-05-15 | Massachusetts Institute Of Technology | Method for enhancing glycoprotein stability |
| CZ298895A3 (en) * | 1993-05-14 | 1996-04-17 | Cytel Corp | Compound analogous to sialyl lex, pharmaceutical composition containing thereof and process for preparing lactosammonium salt |
| SE9301677L (sv) * | 1993-05-14 | 1994-11-18 | Kurt G I Nilsson | Syntesmetod |
-
1997
- 1997-01-17 EP EP97901068A patent/EP0886639B1/de not_active Expired - Lifetime
- 1997-01-17 US US09/117,521 patent/US6187754B1/en not_active Expired - Lifetime
- 1997-01-17 AU AU14446/97A patent/AU1444697A/en not_active Abandoned
- 1997-01-17 WO PCT/EP1997/000223 patent/WO1997028174A1/en not_active Ceased
- 1997-01-17 DE DE69738731T patent/DE69738731D1/de not_active Expired - Lifetime
- 1997-01-17 AT AT97901068T patent/ATE397005T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69738731D1 (de) | 2008-07-10 |
| WO1997028174A1 (en) | 1997-08-07 |
| AU1444697A (en) | 1997-08-22 |
| EP0886639A1 (de) | 1998-12-30 |
| EP0886639B1 (de) | 2008-05-28 |
| US6187754B1 (en) | 2001-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE397005T1 (de) | Sialyl-lewisa und sialyl-lewisx epitope analoge | |
| DE69737496D1 (de) | SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE | |
| ES2101499T3 (es) | Fibras. | |
| PL316658A1 (en) | Novel application of serotonin antagonists | |
| MX9709352A (es) | Derivados de alfa-hortodionina con alto contenido de metionina. | |
| FI962200A0 (fi) | Resonoiva mikrosoninen synteesi | |
| AU2266297A (en) | Recovery of taxanes from conifers | |
| MY131298A (en) | 5-heteroyl indole derivatives | |
| AU3738597A (en) | Molecular model for vla-4 inhibitors | |
| DK0386997T3 (da) | Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler | |
| ES2184127T3 (es) | Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad. | |
| DK0493480T3 (da) | Dehydrodidemnin B | |
| ES2124668B1 (es) | "nuevosl-arilpirazoles con propiedades plaguicidas. | |
| DE59005097D1 (de) | Verwendung härtbarer Cycloaliphaten-Derivate in Dübelmassen. | |
| ES2088076T3 (es) | Piperacinil- y piperidinilciclohexanoles. | |
| BG104117A (en) | Universally applicable blood plasma | |
| FI952797A0 (fi) | D-vitamiinianalogin uusi kiteinen muoto | |
| DE59005206D1 (de) | Gasgenerator. | |
| IT1316986B1 (it) | Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica. | |
| NO975557D0 (no) | Immortalisering og dismortalisering av celler | |
| NO990497L (no) | Modifiserte oligosakkarider | |
| BG101892A (en) | Sugar-modified cytostatics | |
| AR016981A2 (es) | Polipeptidos sinteticos | |
| ES2167748T3 (es) | Derivados del polisacarido k5 con actividad anticoagulante. | |
| ES2134777T3 (es) | Nuevos compuestos de sulfonilo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |